Taken together, our data suggest that inhibition of YAP/TAZ synergizes with KRAS G12C inhibitors to induce robust apoptosis in cancer cells via upregulating the expression of proapoptotic genes such as BCL2L11, BMF, and PUMA (Figure 4G). Here, KRAS is linked to cancer.